|
News | |  |
| | |
|
MUMS Biotechnology Research Center
Nanobiotechnology Department
   
¯ Development of nanolipoparticles containing cytotoxic drugs for the treatment of cancer
¯ Development of vaccine against cutaneous leishmaniasis using new drug delivery systems such as liposomes, nanospheres and nanoemulsions as immunoadjuvant with total leshmanial antigens ( ALM, SLA) or recombinant Antigens (rLmaCIN, rLmSTI1, rGP63)
¯ Development of vaccine against cancer using new drug delivery systems; such as liposomes, nanospheres and nanoemulsions as immunoadjuvant and tumor specific antigens
¯ Developments of topican liposomes containing different anti-leishmanial drugs such as amphotericin B, Glucantim and paromomycin for the treatment of coetaneous leishmanisis
¯ Development of lipid based nanoparticles for nucleic acid delivery
Sonicator (Probe, Bath) – Hemogeniser((Probe Hemogenizer, Bead beater, Microfluidizer) - ElISA Reader - Washer ElISA – Microcentrifuge – Electrophoresis (vertical, horizontal)
| Last Update : 2012-02-09 05:38:22
| |
| | |
Biotechnology Research Center